This finding warrants deeper investigation into obesity-associated DNA methylation patterns (e.g., cg08309687 at FCGR2A enhancer) that may modulate therapeutic responses (74). The gene discussed is FCGR2A; the disease is obesity due to melanocortin 4 receptor deficiency.